欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0940/002
药品名称
Quatriga Low Osmo Peripheral
活性成分
arginine 3.0 g/l
leucine 1.9 g/l
lysine acetate 1.7 g/l
magnesium sulfate 0.3 g/l
soybean oil 11.0 g/l
taurine 0.25 g/l
threonine 1.1 g/l
sodium glycerophosphate 1.0 g/l
sodium acetate 0.85 g/l
serine 1.6 g/l
proline 2.8 g/l
potassium chloride 1.1 g/l
phenylalanine 1.3 g/l
olive oil 8.8 g/l
methionine 1.1 g/l
medium-chain triglycerides 11.0 g/l
isoleucine 1.3 g/l
histidine 0.75 g/l
glycine 2.8 g/l
glucose 68.0 g/l
fish oil, rich in omega 3-acids 5.3 g/l
calcium chloride 0.14 g/l
alanine 3.5 g/l
tyrosine 0.1 g/l
tryptophan 0.5 g/l
zinc sulfate 3.2 mg/l
valine 1.6 g/l
剂型
Emulsion for infusion
上市许可持有人
Fresenius Kabi AB, Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Italy (IT)
许可日期
2021/02/16
最近更新日期
2024/02/21
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Line Extension
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE/H/0940/002_Final PL
Date of last change:2021/03/17
Final SPC
|
SE/H/0940/002_Final SPC
Date of last change:2021/03/17
PAR
|
SE_H_940
PAR Summary
|
SE_H_940_2
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase